Skip to main content

28 publications

Name Date Type Actions

Vétoquinol announces opening of its first decentralized R&D center in Canada

Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital

Voting rights

Vétoquinol to market and distribute Vetprofen in the United States

Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital

Voting rights

3rd quarter revenues confirm promise of
strong growth prospects for 2007

For the nine months ended September 30, 2007, Vétoquinol’s total revenues reached €166.0 M, an increase of 11.3% compared with the
corresponding period in 2006.

Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital

Voting rights

Reports very good first half, confirming that 2007 performance is set to surpass targets

Public releases

Presentation of Vétoquinol’s results for the first half of 2007

2007 Half year results

Public releases

Etats financiers consolidés du 1er semestre 2007 (french)

Half Year Report

Monthly information regarding the total number of voting rights and shares making of the share capital.

Voting rights